Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAMES H SCHULTZ

Allopathic & Osteopathic Physicians Family Medicine

NPI
1356376164
CMS profile
658220
Location
ESCONDIDO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,574.29

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $1,560.00 1
AstraZeneca Pharmaceuticals LP $14.29 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAMES H SCHULTZ

NPI 1356376164 · CMS profile ID 658220

Allopathic & Osteopathic Physicians / Family Medicine

ESCONDIDO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1356376164?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAMES H SCHULTZ, NPI 1356376164, CMS profile ID 658220. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1356376164?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JAMES H SCHULTZ, NPI 1356376164, CMS profile ID 658220. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1356376164?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JAMES H SCHULTZ, NPI 1356376164, CMS profile ID 658220, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1356376164?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $1,574.29 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $1,560.0006/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815523151 CMS
AstraZeneca Pharmaceuticals LP $14.2901/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829808145 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $59.18 3
PY2020 $63.02 3
PY2021 $1,574.29 2
PY2022 $55.88 3
PY2023 $3,863.08 7
PY2024 $2,152.07 33
PY2025 $1,055.00 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $659,253.73 104
PY2024 Recipient $48,637.04 5
PY2024 Principal investigator $695,064.02 430
PY2023 Recipient $11,583.04 6
PY2023 Principal investigator $285,021.08 179
PY2022 Recipient $96,487.00 3
PY2022 Principal investigator $144,410.00 2
PY2020 Principal investigator $92,548.80 14
PY2019 Principal investigator $639,103.36 87

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

435 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Indivior Inc. $144.00 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119472
Principal investigator 1 Indivior Inc. $1,500.00 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119474
Principal investigator 1 Indivior Inc. $187.25 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119694
Principal investigator 1 Indivior Inc. $187.25 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119696
Principal investigator 1 Indivior Inc. $347.50 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119698
Principal investigator 1 Indivior Inc. $187.25 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119700
Principal investigator 1 Indivior Inc. $187.25 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119702
Principal investigator 1 Indivior Inc. $187.25 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119826
Principal investigator 1 Novo Nordisk AS $350.00 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096858131
Principal investigator 1 Novo Nordisk AS $5,128.00 12/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096869363
Principal investigator 1 Eli Lilly and Company $14,053.27 11/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, MULTICENTER, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES, MODERATE OR SEVERE RENAL IMPAIRMENT WITH INADEQUATE GLYCEMIC CONTROL ON BASAL INSULIN WITH OR WITHOUT METFORMIN AND/OR SGLT2 INHIBITOR No dispute reported 06/30/2026 1137362813
Principal investigator 1 Indivior Inc. $347.50 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119108
Principal investigator 1 Indivior Inc. $187.25 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119110
Principal investigator 1 Indivior Inc. $187.25 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144119112
Principal investigator 1 Novo Nordisk AS $1,150.00 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096786881
Principal investigator 1 Novo Nordisk AS $700.00 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096802489
Principal investigator 1 Novo Nordisk AS $3,892.00 11/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096817320
Principal investigator 1 Novo Nordisk AS $8,725.00 10/31/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096800645
Principal investigator 1 Indivior Inc. $187.25 10/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118626
Principal investigator 1 Indivior Inc. $187.25 10/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118628
Principal investigator 1 Indivior Inc. $347.50 10/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118630
Principal investigator 1 Indivior Inc. $347.50 10/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118632
Principal investigator 1 Indivior Inc. $187.25 10/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118634
Recipient Eli Lilly and Company $1,964.00 10/15/2024 Covered Recipient Physician A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1137347791
Recipient Eli Lilly and Company $17,925.00 09/24/2024 Covered Recipient Physician A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137346988
Recipient Eli Lilly and Company $2,367.00 09/24/2024 Covered Recipient Physician A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1137347621
Recipient Eli Lilly and Company $26,362.00 09/24/2024 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1137347789
Principal investigator 1 Novo Nordisk AS $2,900.00 09/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096783981
Principal investigator 1 Novo Nordisk AS $3,150.00 09/20/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096823659
Principal investigator 1 Indivior Inc. $187.25 09/18/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118062
Principal investigator 1 Indivior Inc. $347.50 09/18/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118064
Principal investigator 1 Indivior Inc. $187.25 09/18/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118066
Principal investigator 1 Indivior Inc. $187.25 09/18/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144118068
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096720335
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096722991
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096723635
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096723972
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096726823
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096727893
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096728761
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096728947
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096729322
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096731210
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096732317
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096733141
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096733851
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096735326
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096737156
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096737258
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096738204
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096738436
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096739847
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096741521
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096745361
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096747108
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096747631
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096747975
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096750885
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096752472
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096752947
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096755270
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096755340
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096756907
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096762126
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096765480
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096766089
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096767086
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096769657
Principal investigator 1 Novo Nordisk AS $193.98 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096769805
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096770404
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096770820
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096772202
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096775515
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096776718
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096781361
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096781931
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096782085
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096782135
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096785887
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096786023
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096787757
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096788626
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096790159
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096791048
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096794560
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096796533
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096797619
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096797818
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096798118
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096798787
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096798976
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096799903
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096801689
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096803294
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096803739
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096804343
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096805657
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096806087
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096807205
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096807833
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096812977
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096813458
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096813887
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096814048
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096814329
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096814376
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096814752
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096815235
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096816253
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096816397
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096817325
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096817601
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096818170
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096818658
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096820121
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096821049
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096822456
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096822840
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096823530
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096824435
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096824909
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096826270
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096827164
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096828545
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096830054
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096830448
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096830607
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096830622
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096830847
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096831260
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096831475
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096832517
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096833889
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096837163
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096837817
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096837846
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096838496
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096839512
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096842164
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096843118
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096844665
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096847879
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096849103
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096849585
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096850384
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096850674
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096851968
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096852040
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096852205
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096852575
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096852991
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096853379
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096854819
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096854857
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096855786
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096856798
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096857604
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096858878
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096859503
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096860023
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096860847
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096860860
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096862075
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096862413
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096864172
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096866430
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096866951
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096867680
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096868123
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096869203
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096869898
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096870605
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096871270
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096872011
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096872254
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096873074
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096874066
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096874380
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096875781
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096876908
Principal investigator 1 Novo Nordisk AS $26.86 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096877321
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096877388
Principal investigator 1 Novo Nordisk AS $1.30 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096878683
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096881442
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096881751
Principal investigator 1 Novo Nordisk AS $4.50 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096881947
Principal investigator 1 Novo Nordisk AS $17.90 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096883531
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096883940
Principal investigator 1 Novo Nordisk AS $3.05 09/09/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096884581
Principal investigator 1 Indivior Inc. $192.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117890
Principal investigator 1 Indivior Inc. $282.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117892
Principal investigator 1 Indivior Inc. $50.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117894
Principal investigator 1 Indivior Inc. $524.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117896
Principal investigator 1 Indivior Inc. $643.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117898
Principal investigator 1 Indivior Inc. $50.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117900
Principal investigator 1 Indivior Inc. $224.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117902
Principal investigator 1 Indivior Inc. $415.00 09/04/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117904
Principal investigator 1 Indivior Inc. $347.50 08/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117628
Principal investigator 1 Indivior Inc. $187.25 08/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117630
Principal investigator 1 Indivior Inc. $187.25 08/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117632
Principal investigator 1 Indivior Inc. $187.25 08/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117634
Principal investigator 1 Indivior Inc. $187.25 08/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117636
Principal investigator 1 Novo Nordisk AS $10,582.50 08/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096836838
Principal investigator 1 Novo Nordisk AS $290.00 08/01/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096817620
Principal investigator 1 Novo Nordisk AS $775.00 08/01/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
NN9536-7752 No dispute reported 06/30/2026 1096876696
Principal investigator 1 Indivior Inc. $187.25 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117384
Principal investigator 1 Indivior Inc. $685.00 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117386
Principal investigator 1 Indivior Inc. $187.25 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117388
Principal investigator 1 Indivior Inc. $347.50 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117390
Principal investigator 1 Indivior Inc. $347.50 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117392
Principal investigator 1 Indivior Inc. $187.25 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117394
Principal investigator 1 Novo Nordisk AS $9,597.50 07/22/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096871515
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096719326
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096740663
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096749730
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096795080
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096834839
Principal investigator 1 Novo Nordisk AS $74.95 07/10/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096841916
Principal investigator 1 Eli Lilly and Company $97,451.00 07/08/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1137362703
Principal investigator 1 Eli Lilly and Company $61,736.00 07/08/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH SEMAGLUTIDE ONCE WEEKLY IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN WITH OR WITHOUT SGLT2 INHIBITOR (TRANSCEND-T2D-2) No dispute reported 06/30/2026 1137363521
Principal investigator 1 Indivior Inc. $347.50 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116875
Principal investigator 1 Indivior Inc. $187.25 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116877
Principal investigator 1 Indivior Inc. $187.25 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116879
Principal investigator 1 Indivior Inc. $347.50 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116881
Principal investigator 1 Indivior Inc. $187.25 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144117092
Principal investigator 1 Novo Nordisk AS $10,615.00 06/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096789854
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096738341
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096746530
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096746630
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096747564
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096752979
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096753896
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096754144
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096757972
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096760358
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096761262
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096767276
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096768918
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096775551
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096778752
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096785621
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096789273
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096802210
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096812550
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096812641
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096819476
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096821265
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096830250
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096859644
Principal investigator 1 Novo Nordisk AS $5.20 06/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096879931
Principal investigator 1 Novo Nordisk AS $10,823.00 06/07/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096803041
Principal investigator 1 Eli Lilly and Company $46,635.00 06/03/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE No dispute reported 06/30/2026 1137363713
Principal investigator 1 Novo Nordisk AS $950.00 05/29/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096799136
Principal investigator 1 Novo Nordisk AS $950.00 05/29/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096857780
Principal investigator 1 Indivior Inc. $50.00 05/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116803
Principal investigator 1 Indivior Inc. $388.00 05/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116805
Principal investigator 1 Indivior Inc. $304.00 05/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116807
Principal investigator 1 Indivior Inc. $347.50 05/17/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116661
Principal investigator 1 Indivior Inc. $187.25 05/17/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116663
Principal investigator 1 Indivior Inc. $187.25 05/17/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116665
Principal investigator 1 Indivior Inc. $448.00 05/03/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116505
Principal investigator 1 Indivior Inc. $188.00 05/03/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116507
Principal investigator 1 Novo Nordisk AS $22,076.00 04/30/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096748632
Principal investigator 1 Novo Nordisk AS $1,400.00 04/30/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096802881
Principal investigator 1 Indivior Inc. $187.25 04/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116375
Principal investigator 1 Indivior Inc. $187.25 04/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116377
Principal investigator 1 Indivior Inc. $187.25 04/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116379
Principal investigator 1 Indivior Inc. $187.25 04/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116381
Principal investigator 1 Indivior Inc. $187.25 04/24/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116383
Principal investigator 1 Eli Lilly and Company $187.21 04/18/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE No dispute reported 06/30/2026 1137362701
Principal investigator 1 Indivior Inc. $192.00 04/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116231
Principal investigator 1 Indivior Inc. $224.00 04/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116233
Principal investigator 1 Indivior Inc. $188.00 04/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116239
Principal investigator 1 Indivior Inc. $94.00 04/12/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116241
Recipient Eli Lilly and Company $19.04 04/05/2024 Covered Recipient Physician A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137346986
Principal investigator 1 Novo Nordisk AS $1,746.90 03/27/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096778857
Principal investigator 1 Novo Nordisk AS $4,421.00 03/27/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096850573
Principal investigator 1 Indivior Inc. $187.25 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116089
Principal investigator 1 Indivior Inc. $347.50 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116091
Principal investigator 1 Indivior Inc. $187.25 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116093
Principal investigator 1 Indivior Inc. $347.50 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116095
Principal investigator 1 Indivior Inc. $187.25 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116097
Principal investigator 1 Indivior Inc. $347.50 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116099
Principal investigator 1 Indivior Inc. $685.00 03/25/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144116101
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096721853
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096735689
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096751805
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096782695
Principal investigator 1 Novo Nordisk AS $62.50 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096808842
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096809584
Principal investigator 1 Novo Nordisk AS $38.85 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096821962
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096823667
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096828304
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096842558
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096851796
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096857069
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096873578
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096877841
Principal investigator 1 Novo Nordisk AS $15.80 03/13/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096885239
Principal investigator 1 Indivior Inc. $112.00 03/01/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115931
Principal investigator 1 Eli Lilly and Company $1,729.13 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH SEMAGLUTIDE ONCE WEEKLY IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN WITH OR WITHOUT SGLT2 INHIBITOR (TRANSCEND-T2D-2) No dispute reported 06/30/2026 1137362819
Principal investigator 1 Eli Lilly and Company $4,737.25 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1137363169
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096719825
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096719952
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096724680
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096725291
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096726850
Principal investigator 1 Novo Nordisk AS $50.97 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096731398
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096732998
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096734570
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096738970
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096740529
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096741204
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096743333
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096748595
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096750580
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096752522
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096754338
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096757461
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096757965
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096759490
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096759633
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096761256
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096761698
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096762242
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096763807
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096766886
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096774299
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096774468
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096776608
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096782272
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096782542
Principal investigator 1 Novo Nordisk AS $25.90 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096782707
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096784004
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096786452
Principal investigator 1 Novo Nordisk AS $4.05 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096786586
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096786987
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096788527
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096791202
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096791781
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096791977
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096792266
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096794373
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096794826
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096796059
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096800171
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096804683
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096805260
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096807217
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096807609
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096809243
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096815649
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096817426
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096817924
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096819637
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096820172
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096821531
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096822350
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096822382
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096822460
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096822492
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096822760
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096823252
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096823822
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096826480
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096827068
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096827951
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096828097
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096828457
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096828577
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096829450
Principal investigator 1 Novo Nordisk AS $209.97 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096832887
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096833395
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096833433
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096833718
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096834924
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096835006
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096836936
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096837074
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096837389
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096837516
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096838824
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096838954
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096842951
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096843747
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096844023
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096845063
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096846025
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096847747
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096849706
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096849830
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096854032
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096854407
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096855364
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096857513
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096860646
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096861567
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096861982
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096862676
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096863438
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096864008
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096864746
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096866484
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096866647
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096867393
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096870576
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096870639
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096870936
Principal investigator 1 Novo Nordisk AS $7.80 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096874404
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096875151
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096876775
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096877455
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096878930
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096879490
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096879552
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096881759
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096882248
Principal investigator 1 Novo Nordisk AS $9.75 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096882995
Principal investigator 1 Novo Nordisk AS $16.23 02/28/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE GRAND AVENUE
NN9536-4512 No dispute reported 06/30/2026 1096883607
Principal investigator 1 Indivior Inc. $347.50 02/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115849
Principal investigator 1 Indivior Inc. $187.25 02/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115851
Principal investigator 1 Indivior Inc. $187.25 02/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115853
Principal investigator 1 Indivior Inc. $187.25 02/21/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115855
Principal investigator 1 Indivior Inc. $352.00 02/05/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115687
Principal investigator 1 Indivior Inc. $161.00 02/05/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115689
Principal investigator 1 Eli Lilly and Company $1,632.59 01/31/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137362437
Principal investigator 1 Eli Lilly and Company $5,787.72 01/31/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1137363173
Principal investigator 1 Eli Lilly and Company $1,070.20 01/30/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1137362817
Principal investigator 1 Eli Lilly and Company $108,260.00 01/23/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1137362697
Principal investigator 1 Indivior Inc. $187.25 01/19/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115581
Principal investigator 1 Indivior Inc. $187.25 01/19/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115583
Principal investigator 1 Indivior Inc. $685.00 01/19/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115585
Principal investigator 1 Indivior Inc. $685.00 01/19/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE IV LONGITUDINAL STUDY OF SUBLOCADE (SUBUTEX PROLONGED RELEASE) CLINICAL OUTCOMES IN ADULTS WITH OPIOID USE DISORDER (OPIOID DEPENDENCE) No dispute reported 06/30/2026 1144115587
Principal investigator 1 Eli Lilly and Company $145,560.39 01/08/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1137362815
Principal investigator 1 Eli Lilly and Company $80,407.00 01/02/2024 Non-covered Recipient Entity
NEIGHBORHOOD HEALTHCARE
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1137363365